FDA Inspection
Biocon LimitedBiocon Limited – FDA Inspection, Apr 3, 2017
Record Details
This FDA Inspection record concerns Biocon Limited, with an inspection on April 3, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Michael Shanks (Issuing Officer)
- Reyes Candau-Chacon (Issuing Officer)
- Scott R. Nichols (Issuing Officer)
View Company Profile
ID · a3db8f62-358b-4040-9f8b-9972eef0de49
Inspection Facts
- Inspection number
- 1011618
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Biocon Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | Not classified | Office of Inspections and Investigations | |
| February 26, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 5, 2019 | Not classified | Office of Inspections and Investigations | |
| September 21, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 16, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Biocon Limited
- FDA Inspection 1250808 - 2024-09-20
- FDA Inspection 1120320 - 2020-02-26
- FDA Inspection 1084007 - 2019-03-05
- FDA Inspection 1070344 - 2018-09-21
- FDA Inspection 1044697 - 2018-03-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.